COMPARATIVE STUDY BETWEEN DEXMEDETOMIDINE VERSUS DEXAMETHASONE ALONG WITH 0.5% ROPIVACAINE IN ANAESTHEIC BLOCK GIVEN UNDER ULTRASOUND GUIDANCE AT SUPRACLAVICULAR AREA FOR UPPER LIMB SURGERIES

Phase 4

Not yet recruiting

• Conditions: Diseases of arteries, arterioles and capillaries, (2) ICD-10 Condition: S50-S59||Injuries to the elbow and forearm, (3) ICD-10 Condition: S60-S69||Injuries to the wrist, hand and fingers, (4) ICD-10 Condition: M259||Joint disorder, unspecified,

• Registration Number: CTRI/2021/11/038117
• Lead Sponsor: Dr Anukrishna K V

Brief Summary

This is a comparative study between 2 drugs- dexmedetomidine and dexamethasone when added to another drug ropivacaine when used in ultrasound guided supraclavicular brachial plexus block. Monitoring will be done for onset and duration of sensory and motor blockade,  and will be monitored postoperatively for duration of analgesia. Changes in vitals also will be recorded.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2021-11-17
• Study Start: 2021-11-19

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 62

Inclusion Criteria

Weight between 45 to 70Kgs, posted for elective and emergency surgeries below midarm, forearm and hand will be included.

Exclusion Criteria

History of infection at site of block, history of coagulopathies, patients with known hypersensitivity to local anaesthetic or any study drug, patient with known hypersensitivity to local anaesthetic or any study drug, Patient with presence of 1st, 2nd or 3rd degree heart block, Pregnant women, Patient with pre-existing peripheral neuropathy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To assess the onset of sensory blockade and motor blockade, duration of sensory and motor blockade, duration of analgesia	0,5, 10, 15, 20, 40, 60, 80, 100, 120, 140, 160 400, 640, 880, 1360, 1600 minutes

Secondary Outcome Measures

Name	Time	Method
To assess the total consumption of rescue analgesia in 24 hour postoperatively and to monitor hemodynamic stability	0,5, 10, 15, 20, 40, 60, 80, 100, 120, 140, 160 400, 640, 880, 1360, 1600 minutes

Trial Locations

Locations (1)

MGM Medical college And Hospital; 🇮🇳 Aurangabad, MAHARASHTRA, India

MGM Medical college And Hospital

🇮🇳Aurangabad, MAHARASHTRA, India

Dr Anukrishna KV

Principal investigator

7012861162

anukrishnakv@gmail.com